Attached files

file filename
S-1 - FORM S-1 - Phio Pharmaceuticals Corp.b88518sv1.htm
EX-4.1 - EX-4.1 - Phio Pharmaceuticals Corp.b88518exv4w1.htm
EX-3.2 - EX-3.2 - Phio Pharmaceuticals Corp.b88518exv3w2.htm
EX-4.2 - EX-4.2 - Phio Pharmaceuticals Corp.b88518exv4w2.htm
EX-99.2 - EX-99.2 - Phio Pharmaceuticals Corp.b88518exv99w2.htm
EX-10.9 - EX-10.9 - Phio Pharmaceuticals Corp.b88518exv10w9.htm
EX-10.5 - EX-10.5 - Phio Pharmaceuticals Corp.b88518exv10w5.htm
EX-10.4 - EX-10.4 - Phio Pharmaceuticals Corp.b88518exv10w4.htm
EX-10.3 - EX-10.3 - Phio Pharmaceuticals Corp.b88518exv10w3.htm
EX-23.1 - EX-23.1 - Phio Pharmaceuticals Corp.b88518exv23w1.htm
EX-10.11 - EX-10.11 - Phio Pharmaceuticals Corp.b88518exv10w11.htm
EX-10.10 - EX-10.10 - Phio Pharmaceuticals Corp.b88518exv10w10.htm
Exhibit 99.1
CONSENT OF PROSPECTIVE DIRECTOR
     I, Kevin C. Tang, hereby consent to be named as a prospective director of RXi Pharmaceuticals Corporation in the Registration Statement on Form S-1 of RXi Pharmaceuticals Corporation, and any amendments thereto.
         
     
  /s/ Kevin C. Tang    
  Kevin C. Tang   
Dated: October 24, 2011